HealthQuill HIV
About one in seven adolescents in the age group of 10-19 suffer from mental disorders such as depression and anxiety, according to the WHO.
Drugs Health Pharma

One in seven adolescents globally suffer from mental health disorders 

About one in seven adolescents in the age group of 10-19 suffer from mental disorders such as depression and anxiety, according to the.

Read More
HIV vaccine trials conducted in Eastern and Southern Africa threw up surprising results when more infections were reported in the two vaccine groups than in the placebo or dummy group.
Drugs Health Pharma

PrEPVacc HIV trials’ results ‘surprising’ as dummy group clocks less infections

HIV vaccine trials conducted in Eastern and Southern Africa threw up surprising results when more infections were reported in the two vaccine groups.

Read More
About 400 million people globally live with alcohol and drug use disorders and of the total, 209 million people have alcohol dependence, according to a World Health Organization report.
Drugs Health Pharma

Alcohol claims 2.6 million lives yearly, 209m people are dependent: WHO

About 400 million people globally live with alcohol and drug use disorders and of the total, 209 million people have alcohol dependence, according.

Read More
About 70% of the 4.2 million deaths in 2019 attributed to air pollution were caused by cardiovascular conditions — ischaemic heart disease and stroke, according to a report.
Drugs Health Pharma

One billion people may get better health services by 2025: WHO says

HQ Team May 7, 2024: A target of one billion additional people enjoying better health and well-being is likely to be met by.

Read More
US-based Varda Space Industries’ spacecraft in orbit crystallised a metastable form of a drug for HIV/AIDS — furthering the feasibility of processing pharmaceuticals in microgravity.
Drugs Health Pharma

US-based Varda Space crystallises HIV drug in microgravity

 HQ Team March 31, 2024: US-based Varda Space Industries’ spacecraft in orbit crystallised a metastable form of a drug for HIV/AIDS — furthering.

Read More
The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in South Africa, which has one of the highest burdens in the world.
Drugs Health Pharma

First late-stage trial vaccine doses begin in South Africa for tuberculosis

 HQ Team March 20, 2024: The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in.

Read More
An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but rather strengthened, researchers said.
Drugs Health Pharma

German male injects Covid-19 vaccines 217 times, immunity didn’t weaken

HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but.

Read More
More than 3,700 babies in the US were born with syphilis in 2022 — ten times the number in 2012 — and people from racial and ethnic minorities bore the brunt of the epidemic eight times more than White mothers.
Drugs Health Medical

Newborn syphilis cases rise ten-fold in 2022 in a decade in US: CDC data

More than 3,700 babies in the US were born with syphilis in 2022 — ten times the number in 2012 — and people.

Read More
GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.
Drugs Health Pharma

GSK Plc gets EU approval for HIV prevention drug Apretude

GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.

Read More
Three people have died and 1,020 newly confirmed cases of mpox were reported globally to the WHO during the last 21 days, according to a statement.
Drugs Health Pharma

Mpox virus continues to spread, driven by China’s community transmission 

HQ Team August 15, 2023: Three people have died and 1,020 newly confirmed cases of mpox were reported globally to the WHO during.

Read More